The two teams selected as part of the FNRS-FAPESP call for mobility projects (Brazil) are known! Here they are:

• Benoît HACKENS (FNRS Postdoctoral Researcher, UCLouvain) and Raul de OLIVEIRA FREITAS (Brazilian Synchrotron Light Laboratory) for their project "SynchrotrOn Nanoscale imAging and spectroscopy of Twisted grAphene"
• Mathieu JAVAUX (Professor, UCLouvain) and Quirijn de JONG van LIER (Universidade de São Paulo) for their project "Improving Transpiration and Root water uptake predictions under drought: a comparison of modeling and experimental efforts"

The call for projects was launched at the end of July 2022 as part of the “PINT-BILAT-M” instrument. Funding is granted for bilateral research mobility projects, collaborations between a researcher from the Fédération Wallonie-Bruxelles and a researcher from a FNRS partner agency, in this case FAPESP (Fundação de Amparo à Pesquisa do Estado de São Paolo).

Selected projects receive full funding. Belgian teams funded by the FNRS will receive a maximum amount of €15,000 over a period of two years for travel, scientific workshops/conferences and, possibly, operating costs. The Brazilian teams are funded by FAPESP.

The first transnational call "Transforming Healthcare Systems (THCS)" aims to encourage the optimization of patient care pathways and contribute to the transition towards more sustainable, efficient, resilient, ethical, high-quality, and accessible person-centered healthcare systems. It will open on 14 March.

• More info: https://www.thcspartnership.eu/funding/pre-announcement-of-joint-transnational-call-for-proposals-healthcare-of-the-future-.kl
• Registration for the information webinar (content and how to participate in this call):https://www.zonmw.nl/en/forms/webinar-international-thcs-call-healthcare-of-the-future/

The Audacious Medical Grant (AMG) is a funding tool financed by private donations and legacies received by the FNRS.

It supports medical or biomedical research projects that are original, daring and creative, but which do not find support in traditional funding channels because of a lack of preliminary data, absence of previous work or unusual methodology.

The term "bold" means that there is a significant risk that the project will produce little or no tangible scientific result because of its novelty or complexity.

The AMG-Oncology is not a Télévie-dependent funding instrument but the FNRS uses the expertise of its Scientific Commission to conduct the evaluation of submitted projects. There is therefore no notion of cumulation between the AMG-ONCO 2023 call and the Télévie 2023 call.

• Mini-Guide Audacious Medical Grant - Oncology (AMG-ONCO) 2023

Télévie 2023 call is open on e-space.

• Mini-guide Télévie Call 2023
• Rules and Regulations Télévie (TLV)
• Rules and Regulations Télévie Research Project (PDR-TLV)
• Regulations Télévie Grant (only in FR)
• Regulations Télévie research assistant (only in FR)

IBM Innovation Award

• The Award is granted on the initiative of IBM
• Rewards an oustanding PhD thesis that presents an original contribution to informatics or its applications 
• The informatics part of the work must be both thorough and advanced
• Amount: 5.000 € (for personnal use) 

Eligible topics

Eligibility criteria

• Candidates must  have publicly defended their PhD thesis in 2022 at a university of the Federation Wallonia-Brussels or the Royal Military Academy
• Candidates must be affiliated to a recognized university (within or outside the Federation Wallonia-Brussels) on the date of the submission deadline

How to apply

• The application form duly filled and signed
• The doctoral thesis defence report
• A detailled curriculum vitae
• A complete list of publications
• An electronic version of the thesis